Pediatric Radiology

, Volume 48, Issue 7, pp 999–1007 | Cite as

Reversible lesions of the corpus callosum with initially restricted diffusion in a series of Caucasian children

  • Anthony Le Bras
  • Maia Proisy
  • Mathieu Kuchenbuch
  • Constantin Gomes
  • Catherine Tréguier
  • Sylvia Napuri
  • Emmanuel Quehen
  • Bertrand Bruneau
Original Article



Reversible lesions of the corpus callosum with initial restricted diffusion on diffusion-weighted imaging (DWI) are rare and mainly described in the south Asiatic population.


The purpose of this study was to describe the clinical presentation, imaging findings, prognosis and etiology of transient restricted diffusion lesions of the corpus callosum in a series of Caucasian children.

Materials and methods

Seven children presenting with a transient restricted DWI lesion of the corpus callosum were included. Their clinical presentations and paraclinical examinations were investigated in addition to their MRI findings during the acute phase and at follow-up.


Five patients initially presenting with prodromal flu-like symptoms were diagnosed with mild encephalopathy with reversible corpus callosum lesions, three of which were due to the influenza virus. For two patients (twins) with a stroke-like presentation and without febrile illness, a central nervous system manifestation of X-linked Charcot-Marie-Tooth disease with connexin 32 mutation was diagnosed. All patients had a good clinical prognosis without clinical sequelae or residual MRI lesion for all patients at follow-up.


A transient lesion of the corpus callosum with restricted diffusion should prompt the radiologist to suggest an infectious trigger in children. The prognosis of these patients was good with normalization of clinical symptoms and MRI without any specific treatment.


Central nervous system infections Charcot-Marie-Tooth disease Children Corpus callosum Diffusion-weighted imaging Magnetic resonance imaging Reversible focal lesion 


Compliance with ethical standards

Conflicts of interest



  1. 1.
    Uchino A, Takase Y, Nomiyama K et al (2006) Acquired lesions of the corpus callosum: MR imaging. Eur Radiol 16:905–914CrossRefPubMedGoogle Scholar
  2. 2.
    Doherty MJ, Jayadev S, Watson NF et al (2005) Clinical implications of splenium magnetic resonance imaging signal changes. Arch Neurol 62:433–437CrossRefPubMedGoogle Scholar
  3. 3.
    Starkey J, Kobayashi N, Numaguchi Y, Moritani T (2017) Cytotoxic lesions of the corpus callosum that show restricted diffusion: mechanisms, causes, and manifestations. Radiographics 37:562–576CrossRefPubMedGoogle Scholar
  4. 4.
    Garcia-Monco JC, Cortina IE, Ferreira E et al (2011) Reversible splenial lesion syndrome (RESLES): what’s in a name? J Neuroimaging 21:e1–e14Google Scholar
  5. 5.
    Zhang S, Ma Y, Feng J (2015) Clinicoradiological spectrum of reversible splenial lesion syndrome (RESLES) in adults. Medicine (Baltimore) 94:e512CrossRefGoogle Scholar
  6. 6.
    Tada H, Takanashi J, Barkovich AJ et al (2004) Clinically mild encephalitis/encephalopathy with a reversible splenial lesion. Neurology 63:1854–1858CrossRefPubMedGoogle Scholar
  7. 7.
    Takanashi J, Barkovich AJ, Yamaguchi K, Kohno Y (2004) Influenza-associated encephalitis/encephalopathy with a reversible lesion in the splenium of the corpus callosum: a case report and literature review. AJNR Am J Neuroradiol 25:798–802PubMedGoogle Scholar
  8. 8.
    Takanashi J (2009) Two newly proposed infectious encephalitis/encephalopathy syndromes. Brain Dev 31:521-528CrossRefPubMedGoogle Scholar
  9. 9.
    Takanashi J, Imamura A, Hayakawa F, Terada H (2010) Differences in the time course of splenial and white matter lesions in clinically mild encephalitis/encephalopathy with a reversible splenial lesion (MERS). J Neurol Sci 292:24–27CrossRefPubMedGoogle Scholar
  10. 10.
    Takanashi J, Barkovich AJ, Shiihara T et al (2006) Widening spectrum of a reversible splenial lesion with transiently reduced diffusion. AJNR Am J Neuroradiol 27:836–838PubMedGoogle Scholar
  11. 11.
    Notebaert A, Willems J, Coucke L et al (2013) Expanding the spectrum of MERS type 2 lesions, a particular form of encephalitis. Pediatr Neurol 48:135–138CrossRefPubMedGoogle Scholar
  12. 12.
    Kashiwagi M, Tanabe T, Shimakawa S et al (2014) Clinico-radiological spectrum of reversible splenial lesions in children. Brain Dev 36:330–336CrossRefPubMedGoogle Scholar
  13. 13.
    Ka A, Britton P, Troedson C et al (2015) Mild encephalopathy with reversible splenial lesion: an important differential of encephalitis. Eur J Paediatr Neurol 19:377–382CrossRefPubMedGoogle Scholar
  14. 14.
    Harini C, Das RR, Prabhu SP et al (2015) Clinical and neuroimaging profile of children with lesions in the corpus callosum. J Neuroimaging 25:824–831CrossRefPubMedGoogle Scholar
  15. 15.
    Laothamatas J, Sammet CL, Golay X et al (2014) Transient lesion in the splenium of the corpus callosum in acute uncomplicated falciparum malaria. Am J Trop Med Hyg 90:1117–1123CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Hashimoto Y, Takanashi J, Kaiho K et al (2009) A splenial lesion with transiently reduced diffusion in clinically mild encephalitis is not always reversible: A case report. Brain Dev 31:710-712CrossRefPubMedGoogle Scholar
  17. 17.
    Kagawa K, Okada H (2009) Reversible splenial lesion of the corpus callosum on diffusion-weighted magnetic resonance imaging in hypoglycemic hemiparesis: report of two cases. No Shinkei Geka 37:473–478PubMedGoogle Scholar
  18. 18.
    Malik AM (2013) The reversible corpus callosum splenium lesion associated with hypoglycemic encephalopathy. Neurohospitalist 3:169CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Kim JH, Choi JY, Koh S-B, Lee Y (2007) Reversible splenial abnormality in hypoglycemic encephalopathy. Neuroradiology 49:217–222CrossRefPubMedGoogle Scholar
  20. 20.
    Maeda M, Tsukahara H, Terada H et al (2006) Reversible splenial lesion with restricted diffusion in a wide spectrum of diseases and conditions. J Neuroradiol 33:229–236CrossRefPubMedGoogle Scholar
  21. 21.
    Hackett PH, Yarnell PR, Hill R et al (1998) High-altitude cerebral edema evaluated with magnetic resonance imaging: clinical correlation and pathophysiology. JAMA 280:1920–1925CrossRefPubMedGoogle Scholar
  22. 22.
    Kim SS, Chang KH, Kim ST et al (1999) Focal lesion in the splenium of the corpus callosum in epileptic patients: antiepileptic drug toxicity? AJNR Am J Neuroradiol 20:125–129PubMedGoogle Scholar
  23. 23.
    Güven H, Delibaş S, Comoğlu SS (2008) Transient lesion in the splenium of the corpus callosum due to carbamazepine. Turk Neurosurg 18:264–270PubMedGoogle Scholar
  24. 24.
    Gürtler S, Ebner A, Tuxhorn I et al (2005) Transient lesion in the splenium of the corpus callosum and antiepileptic drug withdrawal. Neurology 65:1032–1036CrossRefPubMedGoogle Scholar
  25. 25.
    Mori H, Maeda M, Takanashi J et al (2012) Reversible splenial lesion in the corpus callosum following rapid withdrawal of carbamazepine after neurosurgical decompression for trigeminal neuralgia. J Clin Neurosci 19:1182–1184CrossRefPubMedGoogle Scholar
  26. 26.
    Loes DJ, Fatemi A, Melhem ER et al (2003) Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology 61:369–374CrossRefPubMedGoogle Scholar
  27. 27.
    Kim JH, Kim HJ (2005) Childhood X-linked adrenoleukodystrophy: clinical-pathologic overview and MR imaging manifestations at initial evaluation and follow-up. Radiographics 25:619–631CrossRefPubMedGoogle Scholar
  28. 28.
    Siskind C, Feely SME, Bernes S et al (2009) Persistent CNS dysfunction in a boy with CMT1X. J Neurol Sci 279:109–113CrossRefPubMedGoogle Scholar
  29. 29.
    Basri R, Yabe I, Soma H et al (2007) X-linked Charcot-Marie-Tooth disease (CMTX) in a severely affected female patient with scattered lesions in cerebral white matter. Intern Med 46:1023–1027CrossRefPubMedGoogle Scholar
  30. 30.
    Al-Mateen M, Craig AK, Chance PF (2014) The central nervous system phenotype of X-linked Charcot-Marie-Tooth disease: a transient disorder of children and young adults. J Child Neurol 29:342–348CrossRefPubMedGoogle Scholar
  31. 31.
    Anand G, Maheshwari N, Roberts D et al (2010) X-linked hereditary motor sensory neuropathy (type 1) presenting with a stroke-like episode. Dev Med Child Neurol 52:677–679CrossRefPubMedGoogle Scholar
  32. 32.
    Paulson HL, Garbern JY, Hoban TF et al (2002) Transient central nervous system white matter abnormality in X-linked Charcot-Marie-Tooth disease. Ann Neurol 52:429–434CrossRefPubMedGoogle Scholar
  33. 33.
    Wang Y, Yin F (2015) A review of X-linked Charcot-Marie-Tooth disease. J Child Neurol 31:761–772CrossRefPubMedGoogle Scholar
  34. 34.
    Kassubek J, Bretschneider V, Sperfeld A-D (2005) Corticospinal tract MRI hyperintensity in X-linked Charcot-Marie-Tooth disease. J Clin Neurosci 12:588–589CrossRefPubMedGoogle Scholar
  35. 35.
    Imamura T, Takanashi J, Yasugi J et al (2010) Sisters with clinically mild encephalopathy with a reversible splenial lesion (MERS)-like features; Familial MERS? J Neurol Sci 290:153–156CrossRefPubMedGoogle Scholar
  36. 36.
    Morichi S, Kawashima H, Ioi H et al (2012) High production of interleukin-10 and interferon-γ in influenza-associated MERS in the early phase. Pediatr Int 54:536–538CrossRefPubMedGoogle Scholar
  37. 37.
    Bulakbasi N, KocaogluM, Tayfun C, Ucoz T (2006) Transient splenial lesion of the corpus callosum in clinicallymild influenza-associated encephalitis/encephalopathy. AJNR Am J Neuroradiol 27:1983–1986Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Medical ImagingHôpital Sud, CHU de RennesRennesFrance
  2. 2.Department of Pediatric NeurologyHôpital sud, CHU RennesRennesFrance
  3. 3.Department of Medical ImagingCHU PontchaillouRennesFrance

Personalised recommendations